Contact Us |  Careers | News | Terms and Conditions

text text text text text

We're a global company focused on sophisticated products.

As one of the world's leading osmotic drug delivery companies, Osmotica Pharmaceutical is leveraging its significant resources in R&D and proprietary drug delivery technology to address the growing needs of the global patient population.
Learn more. >>
We don't just face challenges, we overcome them.
Osmotica has developed a broad portfolio of intellectual property including issued and pending patents and proprietary know-how. We're expanding our osmotic capabilities and actively developing next-generation, non-osmotic technologies.
Learn more. >>

October 17, 2013
Osmotica Pharmaceutical Corp. Announces the Appointment of Kenneth Gayron as Vice President and Chief Financial Officer
September 27, 2013
Osmotica Announces the Commercial Launch of Its KHEDEZLA™ (desvenlafaxine) Extended-release Tablets, 50 mg and 100 mg
September 6, 2013
Osmotica Announces the Appointment of Gene Wright, Pharm.D., Ph.D. as VP, Head of Global Clinical Development